New drug class could treat range of cancers with faulty BRCA genes 17 Jun 2021 Scientists have identified a new class of targeted cancer drugs that offer the potential to treat patients whose tumours have faulty copies of the BRCA cancer genes. Find out more Show/Hide
Trial shows benefits of targeted drug against early-stage breast cancer with inherited BRCA mutation 03 Jun 2021 Women with high-risk, early-stage breast cancer who also have inherited faults in their BRCA1 or BRCA2 genes have shown a remarkable response to the targeted drug olaparib in a major clinical trial. Find out more Show/Hide
Leading breast cancer researcher elected as Fellow of the Academy of Medical Sciences 12 May 2021 Professor Nicholas Turner has been recognised with a prestigious Fellowship of the Academy of Medical Sciences for his excellence in breast cancer research and outstanding contribution to the field. Find out more Show/Hide
Common antiseptic could be cheap and easy way to improve cancer radiotherapy around the world 03 Feb 2021
Existing breast cancer drug offers new targeted treatment for triple negative breast cancer 28 Jan 2021
New study sheds light on the best drug choices for some patients with advanced breast cancer 08 Oct 2020
ESMO 2020: Research breakthrough offers new hope for high risk patients with HR+ breast cancer 20 Sep 2020
Major ‘plasmaMATCH’ trial uses blood test to match women with breast cancer to range of precision treatments 10 Sep 2020